These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Repeat prescriptions of guideline-based secondary prevention medication in patients with type 2 diabetes and previous myocardial infarction in Dutch primary care. Kasteleyn MJ; Wezendonk A; Vos RC; Numans ME; Jansen H; Rutten GE Fam Pract; 2014 Dec; 31(6):688-93. PubMed ID: 25106412 [TBL] [Abstract][Full Text] [Related]
6. Medical compliance to evidence-based clinical guidelines on secondary prevention of coronary heart disease in a hospital from Lima, Peru: a retrospective study. Castañeda-Amado Z; Calixto-Aguilar L; Loza Munarriz C; Medina Palomino FA Medwave; 2017 Jun; 17(5):e6989. PubMed ID: 28665919 [TBL] [Abstract][Full Text] [Related]
7. Achieving national service framework standards for cardiac rehabilitation and secondary prevention. Dalal HM; Evans PH BMJ; 2003 Mar; 326(7387):481-4. PubMed ID: 12609946 [TBL] [Abstract][Full Text] [Related]
9. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry. Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960 [TBL] [Abstract][Full Text] [Related]
10. Increasing Cardiac Rehabilitation Participation From 20% to 70%: A Road Map From the Million Hearts Cardiac Rehabilitation Collaborative. Ades PA; Keteyian SJ; Wright JS; Hamm LF; Lui K; Newlin K; Shepard DS; Thomas RJ Mayo Clin Proc; 2017 Feb; 92(2):234-242. PubMed ID: 27855953 [TBL] [Abstract][Full Text] [Related]
11. API expert consensus document on management of ischemic heart disease. Association of Physicians of India J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697 [TBL] [Abstract][Full Text] [Related]
12. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D; Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109 [TBL] [Abstract][Full Text] [Related]
13. Lipid Testing and Statin Dosing After Acute Myocardial Infarction. Wang WT; Hellkamp A; Doll JA; Thomas L; Navar AM; Fonarow GC; Julien HM; Peterson ED; Wang TY J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29371200 [TBL] [Abstract][Full Text] [Related]
14. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication. Di Martino M; Alagna M; Lallo A; Gilmore KJ; Francesconi P; Profili F; Scondotto S; Fantaci G; Trifirò G; Isgrò V; Davoli M; Fusco D BMC Cardiovasc Disord; 2021 Apr; 21(1):180. PubMed ID: 33853534 [TBL] [Abstract][Full Text] [Related]